Hemispherx Biopharma Second Quarter 2006 Earnings Announced; Cash And Cash Equivalents Increased $5.3 Million For Six Months Ended June 30, 2006

Hemispherx Biopharma, Inc. (AMEX: HEB) announced earnings for the three months ended June 30, 2006. The net loss for this period, including non-cash finance charges, was approximately $5,081,000 or $0.08 per share compared to losses of $3,345,000 or $0.07 per share, for the same period in 2005.